Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53M
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
16.1M
-
Shares change
-
+1.66M
-
Total reported value, excl. options
-
$174M
-
Value change
-
+$5.02M
-
Number of buys
-
36
-
Number of sells
-
-25
-
Price
-
$10.83
Significant Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q4 2018
74 filings reported holding CDLX - Cardlytics, Inc. - Common Stock, par value $0.0001 as of Q4 2018.
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.1M shares
of 53M outstanding shares and own 30.34% of the company stock.
Largest 10 shareholders include FMR LLC (3.21M shares), Polaris Venture Management Co. V, L.L.C. (2.55M shares), Canaan Partners VIII LLC (2.37M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1.46M shares), JENNISON ASSOCIATES LLC (1.26M shares), Voya Investment Management LLC (672K shares), CANNELL CAPITAL LLC (507K shares), Vanguard Group Inc (498K shares), DISCOVERY CAPITAL MANAGEMENT, LLC / CT (429K shares), and BlackRock Inc. (423K shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.